Loading clinical trials...

Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT00411528

Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer

The objective of this study is to assess the response of patupilone plus prednisone compared to docetaxel plus prednisone on prostate specific antigen (PSA) in patients with metastatic hormone refract...

Lead sponsor: Novartis Pharmaceuticals•11 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Related studies

COMPLETEDPhase 2

PHA-739358 for Treatment of Hormone Refractory Prostate Cancer

NCT00766324 · Metastatic Hormone Refractory Prostate Cancer

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 17, 2020Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment185

Start dateSep 2006

Last updatedDec 17, 2020

Condition

Metastatic Hormone Refractory Prostate Cancer

Locations shown

University of California San Diego Dept of Moores Cancer Center

La Jolla, California

University of Colorado Dept. of Univ. of Colorado

Aurora, Colorado

Norwalk Hospital

Norwalk, Connecticut

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 17, 2020Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions